SEC Filing Analysis: Nebius Group N.V. (NBIS)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Director Matthew Robert Weigand received a routine equity grant of 1,352 restricted share units (RSUs) vesting in January 2027.
• Market Impact: Neutral; standard director equity compensation with zero open-market capital outlay and negligible dilution.

Company & Insider Information

Field	Value
Company	Nebius Group N.V. (NBIS)
CIK	0001513845
Insider Name	Matthew Robert Weigand
Insider Relationship	Director
Insider CIK	0002083213

Transaction Details

Field	Value
Form Type	Form 4
Transaction Date	2026-09-01
Transaction Code	A (Award / Grant)
Security Type	Class A Shares (RSUs)
Shares Transacted	1,352
Price Per Share	$0.00
Total Transaction Value	$0.00
Shares Owned Following Transaction	14,987
Ownership Nature	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Market Capitalization	$56.90 billion
Shares Outstanding	253,900,000
Transaction Value % of Market Cap	0.00%
Shares Transacted % of Outstanding	0.00053%
Post-Transaction Ownership	14,987 shares (0.0059% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a large-cap company valued at $56.90B, a 1,352 share grant is purely administrative compensation.
• Dilution Impact: Dilution is practically non-existent at ~0.0005% of outstanding shares.
• Ownership Context: Holdings include 9,102 shares received via pro-rata distributions from Accel-affiliated funds pursuant to Rule 16a-13.

Market Impact Analysis

• Direction: Neutral
• Reasoning: Routine equity compensation award under the company's Amended and Restated Equity Incentive Plan without open-market buying or selling activity.
• Expected Volume Impact: None
• Sentiment Indicator: Neutral

Additional Context

• Vesting Terms: RSUs vest in full on January 2, 2027.
• Foreign Private Issuer Status: Transactions are exempt from Section 16(b) short-swing profit rules pursuant to Rule 3a12-3(b).